F2-isoprostanes from arachidonic acid -: Biomarkers of oxidative stress?

被引:0
|
作者
Schmandke, H
机构
来源
ERNAHRUNGS UMSCHAU | 2000年 / 47卷 / 05期
关键词
F-2-isoprostanes; biomarkers; oxidative stress;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
F-2-isoprostanes (F-2-IsoP) are prostaglandin isomers formed from arachidonic acid in a cyclooxigenase-independent free radical-catalyzed mechanism. Therefore they are potential indicators of oxidative stress. From the theoretically possible 64 isomers hitherto 15-F-2t- IsoP, 5-F-2t-IsoP, 5-F-2c-IsoP and 5-epi-5-F-2c-IsoP have been identified in humans. F-2-IsoP undergo beta-oxidation. 2,3-Diner-15 F-2t and 2,3-Diaor-5,6-dihydro-15-F-2t-IsoP are the identified metabolites. 15-F-2t IsoP is a potent smooth muscle cell constrictor modulating platelets as well as inducing proliferation of vascular smooth muscle cells. F-2t IsoP are measured after chromatographic purification by GC/MS, immune-enzyme or radioimmuno-assays. 15-F-2t-IsoP has been found in blood plasma, atherosclerotic lesions and urine of humans, 5-F-2t-IsoP in blood plasma and urine. 5-F-2c- and 5-epi-5-F-2c-IsoP were identified in urine. In the case ofnon-insuline dependent diabetes mellitus and smokers, the 15-F-2t-IsoP values are increased in blood plasma, atherosclerotic lesions and in that of hypercholesterolemia in LDL. in urine the amounts of 15-F-2t- and 5-F-2t-IsoP are increased in smokers and hypercholesterolemic persons. ol-Tocopherol supplementation decreases the urinary content of F-2-IsoP to normal levels. Supplementation of soy isoflavonoids does not influence urine level of F-2-IsoP in subjects with high-normal blood pressure. Urinary 15-F-2t-TsoP excretion is not dependent on the lipid content of the diet, but increased by a 24 h fasting period. A correlation between oxidative stress and risk factors for coronary heart disease is obvious.
引用
收藏
页码:172 / +
页数:6
相关论文
共 50 条
  • [21] Systemic oxidative stress, as measured by urinary allantoin and F2-isoprostanes, is not increased in Down syndrome
    Tolun, Adviye A.
    Scarbrough, Peter M.
    Zhang, Haoyue
    McKillop, Jane-Ann
    Wang, Frances
    Kishnani, Priya S.
    Millington, David S.
    Young, Sarah P.
    Il'yasova, Dora
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (12) : 892 - 894
  • [22] Follicular fluid F2-isoprostanes: A novel assessment of oxidative stress in IVF patients.
    Lin, K
    Barnhart, K
    Shaunik, A
    Butts, S
    Fitzgerald, GA
    Coutifaris, C
    FERTILITY AND STERILITY, 2005, 84 : S47 - S47
  • [23] Bioactive eicosanoids: Role of prostaglandin F2α and F2-isoprostanes in inflammation and oxidative stress related pathology
    Basu, Samar
    MOLECULES AND CELLS, 2010, 30 (05) : 383 - 391
  • [24] Correlation among anemia, inflammation and products of arachidonic acid oxidation (F2-isoprostanes) in chronic renal failure
    Carluccio, F.
    Siems, W.
    Wiswedel, I.
    Luno, J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 209 - 209
  • [25] F2-isoprostanes and hepatic fibrosis
    Comporti, M
    Arezzini, B
    Signorini, C
    Sgherri, C
    Vecchio, D
    Monaco, B
    Gardi, C
    SFRR: PROCEEDINGS OF THE XII BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, 2004, : 267 - 272
  • [26] Plasma F2-isoprostanes are a marker of oxidative stress which are elevated in patients with unstable coronary syndromes
    Best, PJM
    Wilson, SH
    Richardson, D
    Holmes, DR
    Lerman, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 404A - 404A
  • [27] Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome
    Chen, Shih-Pin
    Chung, Yu-Ting
    Liu, Tsung-Yun
    Wang, Yen-Feng
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 61 : 243 - 248
  • [28] F2-isoprostanes as biomarkers of late-onset Alzheimer's disease
    Montine, Thomas J.
    Quinn, Joseph
    Kaye, Jeffrey
    Morrow, Jason D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2007, 33 (01) : 114 - 119
  • [29] Plasma Esterified F2-Isoprostanes and Oxidative Stress in Newborns: Role of Nonprotein-Bound Iron
    Cinzia Signorini
    Serafina Perrone
    Cristiana Sgherri
    Lucia Ciccoli
    Giuseppe Buonocore
    Silvia Leoncini
    Viviana Rossi
    Daniela Vecchio
    Mario Comporti
    Pediatric Research, 2008, 63 : 287 - 291
  • [30] Plasma esterified F2-isoprostanes and oxidative stress in newborns:: Role of nonprotein-bound iron
    Signorini, Cinzia
    Perrone, Serafina
    Sgherri, Cristiana
    Ciccoli, Lucia
    Buonocore, Giuseppe
    Leoncini, Silvia
    Rossi, Viviana
    Vecchio, Daniela
    Comporti, Mario
    PEDIATRIC RESEARCH, 2008, 63 (03) : 287 - 291